A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-1293 Compared With a Basal Insulin in Participants With Type 1 Diabetes (MK-1293-005)
Clinical trial NCT02059174 · COMPLETED
Trial details
- NCT number
- NCT02059174
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-10
- Primary completion
- 2015-03-30
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.